Serum IgA/C3 ratio may be a useful marker of disease activity in severe Henoch-Schönlein nephritis

Nephron - Clinical Practice

Volumn 101, Issue 2, 2005, Pages

  Jae, Il Shin ^a   Jee, Min Park ^a   Youn, Ho Shin ^a   Jae, Seung Lee ^a   Hyeon, Joo Jeong ^a   Hyon, Suk Kim ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Activity index; Henoch Sch nlein nephritis; IgA C3 ratio; Serologic marker

Indexed keywords

COMPLEMENT COMPONENT C3; CYCLOSPORIN; IMMUNOGLOBULIN A; PREDNISOLONE; STEROID;

ADOLESCENT; ANAPHYLACTOID PURPURA; ARTICLE; CHILD; CLINICAL ARTICLE; COMPLEMENT BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE MARKER; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN BLOOD LEVEL; KIDNEY BIOPSY; KIDNEY DISEASE; MALE; NEPHRITIS; PREDICTION; PRIORITY JOURNAL; REMISSION; SCORING SYSTEM; STATISTICAL SIGNIFICANCE;

ADOLESCENT; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; COMPLEMENT C3; FEMALE; HUMANS; IMMUNOGLOBULIN A; MALE; NEPHRITIS; PURPURA, SCHOENLEIN-HENOCH; SEVERITY OF ILLNESS INDEX;

EID: 23944438392     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000086225     Document Type: Article

References (26)

1. Austin HA, Balow JE: Henoch-Schönlein nephritis: Prognostic features and the challenge of therapy. Am J Kidney Dis 1983;2:512-520.
2. Davin J-C, Weening JJ: Henoch-Schönlein purpura nephritis: An update. Eur J Pediatr 2001;160:689-695.
3. Goldstein AR, White RHR, Akuse R, Chantler C: Long-term follow-up of childhood Henoch-Schönlein nephritis. Lancet 1992;339:280-282.
4. Ronkainen J, Nuutinen M, Koskimies O: The adult kidney 24 years after childhood Henoch-Schönlein purpura. A retrospective cohort study. Lancet 2002;360:666-670.
5. Tarshish P, Bernstein J, Edelmann CM: Henoch-Schönlein purpura nephritis: Course of disease and efficacy of cyclophosphamide. Pediatr Nephrol 2004;19:51-56.
6. Bohle A, Wehrmann M, Bogenschutz O: The long-term prognosis of the primary glomerulonephritides: A morphological and clinical analysis of 1,747 cases. Pathol Res Pract 1992;188:908-924.
7. Zwirner J, Burg M, Schulze M, Brunkhorst R, Götze O, Koch KM, Floege J: Activated complement C3: A potentially novel predictor of progressive IgA nephropathy. Kidney Int 1997;51:1257-1264.
8. Ishiguro C, Yaguchi Y, Funabiki K, Horikoshi S, Shirato I, Tomino Y: Serum IgA/C3 ratio may predict diagnosis and prognostic grading in patients with IgA nephropathy. Nephron 2002;91:755-758.
9. Maeda A, Gohda T, Funabiki K, Horikoshi S, Shirato I, Tomino Y: Significance of serum IgA levels and serum IgA/C3 ratio in diagnostic analysis of patients with IgA nephropathy. J Clin Lab Anal 2003;17:73-76.
10. Meadow SR, Glasgow EF, White RHR, Moncrief MW, Cameron JS, Ogg CS: Schönlein-Henoch nephritis. Q J Med 1972;41:241-258.
11. Fink PC, Romer M, Haeckel R, Fateh-Moghadam A, Delanghe J, Gressner AM, Dubs RW: Measurement of proteins with the Behring nephelometer. A multicenter evaluation. J Clin Chem Clin Biochem 1989;27:261-276.
12. Counahan R, Winterborn MH, White RHR, Heaton JM, Meadow SR, Bluett NH, Swetschin H, Cameron JS, Chantler C: Prognosis of Henoch-Schönlein nephritis in children. Br Med J 1977;2:11-14.
13. Andreoli SP, Bergstein J: Treatment of severe IgA nephropathy in children. Pediatr Nephrol 1989;3:248-253.
14. Foster BJ, Bernard C, Drummond KN, Sharma AK: Effective therapy for severe HSP nephritis with prednisone and azathioprine: A clinical and histopathological study. J Pediatr 2000;136:370-375.
15. Knight JF: The rheumatic poison: A survey of some published investigations of the immunopathogenesis of Henoch-Schönlein purpura. Pediatric Nephrol 1990;4:533-541.
16. Davin JC, ten Berghe I, Weening JJ: Henoch-Schönlein purpura nephritis and IgA nephropathy: What makes the difference? Kidney Int 2001;59:823-834.
17. Allen AC, Willis FR, Beattie J, Feehally J: Abnormal IgA glycosylation in Henoch-Schönlein purpura restricted to patients with clinical nephritis. Nephrol Dial Transplant 1998;13:930-934.
18. Feehally J, Allen AC: Pathogenesis of IgA nephropathy. Ann Med Interne (Paris) 1999;150:91-98.
19. Tomino Y, Sakai H; Special Study Group (IgA Nephropathy) on Progressive Glomerular Disease: Clinical guidelines for immunoglobulin A (IgA) nephropathy in Japan, second version. Clin Exp Nephrol 2003;7:93-97.
20. Davin JC, Vandenbroeck MC, Foidart JB, Mahieu PR: Sequential measurements of the reticuloendothelial system function in Henoch-Schönlein disease in childhood. Correlation with various immunological parameters. Acta Paediatr Scand 1985;74:201-206.
21. Garcia-Fuentes M, Martin A, Chantler C, Williams DG: Serum complement components in Henoch-Schönlein purpura. Arch Dis Child 1978;53:417-419.
22. Smith GC, Joyce ED, Hughes DA, Holme E, Beattie TJ: Complement activation in Henoch-Schönlein purpura. Pediatr Nephrol 1997;11:477-480.
23. Ronkainen J, Autio-Harmainen H, Nuutinen M: Cyclosporin A for the treatment of severe Henoch-Schönlein glomerulonephritis. Pediatr Nephrol 2003;18:1138-1142.
24. Niaudet P, Habib R: Methylprednisolone pulse therapy in the treatment of severe forms of Schönlein-Henoch nephritis. Pediatr Nephrol 1998;12:238-243.
25. Rieu P, Noel LH: Henoch-Schönlein nephritis in children and adults: Morphological features and clinicopathological correlations. Ann Med Interne (Paris) 1999;150:151-159.
26. Ronkainen J, Ala-Houhala M, Huttunen N-P, Jahnukainen T, Koskimies O, Örmälä T, Nuutinen M: Outcome of Henoch-Schönlein nephritis with nephrotic-range proteinuria. Clin Nephrol 2003;60:80-84.